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Diisocyanates are commercially important,
toxic, human-made chemicals used in the
manufacture of polyurethane (1,2). Although
strict standards have been mandated by the
U.S. Occupational Safety and Health
Administration to limit respiratory tract expo-
sure to these chemicals, diisocyanates remain a
leading cause of occupational asthma world-
wide (1,2). Environmental exposures to diiso-
cyanates have been documented in individuals
living near production facilities and may also
occur in proximity to end-use settings in resi-
dential neighborhoods (3). Hexamethylene
diisocyanate (HDI), the focus of this study, is
one of the most commonly used diisocyanates
and is employed in autobody spray paints, the
manufacture of spinnable fibers, and the
preservation of animal hides (4).
The effects of HDI on airway epithelial
cells remain poorly described despite the doc-
umented susceptibility of airway epithelial cell
proteins to diisocyanate conjugation (5,6) and
their anatomical location at the air–liquid
interface in the lung, a primary site of expo-
sure. Our laboratory has recently identified
speciﬁc epithelial cell proteins that selectively
become conjugated with HDI after exposure,
including keratin 18, dihydrodiol dehydroge-
nase, actin, and the 78-kDa glucose-regulated
stress response protein (6). In addition, Lange
et al. (7) have shown that toluene diisocyanate
(TDI) colocalizes with tubulin present in the
cilia of differentiated human airway epithelial
cells. Thus, airway epithelial cell proteins may
serve as biologically relevant carriers that
present HDI to the human immune system
after inhalation, thereby mediating diiso-
cyanate-induced airway inﬂammation (5,8).
The functional consequences of HDI expo-
sure on airway epithelial cells, including protein
conjugation and potential effects on cellular
homeostasis, remain unclear. Limited studies to
date have suggested that cellular thiols may be
especially sensitive to diisocyanate exposure
under physiologic conditions. Occupationally
relevant doses of TDI have been shown to
cause a rapid reduction of glutathione levels in
normal human bronchial epithelial cells in vitro
(9–11). It remains unclear whether TDI-
induced changes in glutathione levels are a
direct effect of exposure or secondary to protec-
tive mechanisms such as oxidant injury-
induced protein glutathionylation (12).
However, these data clearly demonstrate the
potential for diisocyanates to alter airway
epithelial cell thiol-redox homeostasis, an
important modulator of numerous genes under
the control of redox-sensitive transcription fac-
tors such as NFκB, Ref-1, and AP-1 (13,14).
Thus, studies to date suggest that HDI
and other diisocyanates react with specific
proteins in human airway epithelial cells and
may modulate cellular thiol-redox homeosta-
sis through unknown mechanisms. However,
the physical interactions of HDI with airway
cells and the potential effects of HDI on gene
expression remain poorly characterized. In
this study, we developed an in vitro model to
further characterize the binding and uptake of
HDI as well as the molecular effects of
exposure on human airway epithelial cells. The
studies were made possible by using recently
developed reagents and methodologies, includ-
ing an HDI-speciﬁc polyclonal antiserum gen-
erated by our laboratory and microarray
technology. The sensitivity of immunocyto-
chemical approaches and the broad-scope mol-
ecular analysis achievable with microarrays are
uniquely applicable to such exploratory investi-
gations. The present studies are the ﬁrst we are
aware of to exploit microarray technology to
investigate the effects of HDI and illustrate the
potential utility of this novel technique in
studying the response of human airway epithe-
lial cells to exposure. The results of the in vitro
cellular and molecular studies provide new data
on the effects of HDI on human airway epithe-
lial cells and identify speciﬁc genes that may be
important in the acute response to exposure.
Materials and Methods
Reagents and cell lines. We purchased HDI,
CaCl2, MgCl2 endotoxin-free water, and strep-
tomycin/penicillin from Sigma Chemical
Company (St. Louis, MO). Northern Max-Gly
kit, ULTRAhyb Buffer, Brightstar Psoralen-
Biotin Nonisotopic Labeling Kit, and CDP-
Star/Brightstar Biodetect kit were from
Ambion (Austin, TX). Fetal bovine serum
(FBS), RPMI 1640, gentamicin, L-glutamine,
phosphate-buffered saline (PBS), Trizol, trypan
blue, trypsin-EDTA, and nonessential amino
acids (NEAA) were from Gibco BRL Life
Technologies (Grand Island, NY). Hybond-N
nylon membrane was from Amersham
Pharmacia Biotech (Piscataway, NJ); triton
X-100, from Calbiochem (La Jolla, CA); rho-
damine anti-rabbit immunoglobulin γ, from
Santa Cruz (Santa Cruz, CA); acetone, from
JT Baker Company (Phillipsburg, NJ); pro-
long antifade mounting media, from
Molecular Probes (Eugene, OR); RNAeasy
Minikit, from Qiagen (Valencia, CA).
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In this study we developed an in vitro exposure model to investigate the effects of hexamethylene
diisocyanate (HDI) on human airway epithelial cells at the cellular and molecular level. We used
immunoﬂuorescence analysis (IFA) to visualize the binding and uptake of HDI by airway epithe-
lial cell lines (A549 and NCI-NCI-H292) and microarray technology to identify HDI sensitive
genes. By IFA, we observed that subcytotoxic concentrations of HDI form microscopic micelles
that appear to be taken up by cells over a 3-hr period postexposure. Microarray analysis (4.6K
genes) of parallel cultures identiﬁed four genes (thioredoxin reductase, dihydrodiol dehydrogenase,
TG interacting factor, and stanniocalcin) whose mRNA levels were up-regulated after HDI expo-
sure. Northern analysis was used to conﬁrm that HDI increased message levels of these four genes
and to further explore the dose dependence and kinetics of the response. The ﬁnding that HDI
exposure increases thioredoxin reductase expression supports previous studies suggesting that HDI
alters thiol-redox homeostasis, an important sensor of cellular stress. Another of the HDI-
increased genes, a dihydrodiol dehydrogenase, encodes a protein previously shown to be speciﬁ-
cally susceptible to HDI conjugation, and known to detoxify other hydrocarbons. Together, the
data describe a novel approach for investigating the effects of HDI binding and uptake by human
airway epithelial cells and begin to identify genes that may be involved in the acute response to
exposure. Key words: exposure, hexamethylene diisocyanate, human airway epithelial cell, redox,
thiol, thioredoxin reductase. Environ Health Perspect 110:901–907 (2002). [Online 25 July 2002]
http://ehpnet1.niehs.nih.gov/docs/2002/110p901-907wisnewski/abstract.htmlHuman airway epithelial cell lines A549 and
NCI-H292 were obtained from the American
Type Culture Collection (Rockville, MD).
Cell culture. Human airway epithelial cell
lines A549 and NCI-H292 were maintained
in RPMI 1640 supplemented with 10% FBS,
2 mM L-glutamine, 1 mM NEAA, 10 U/mL
streptomycin/penicillin, and 10 µg/mL gen-
tamicin. Cells were grown in a 75-cm2 tissue
culture flask and passaged as needed by
trypsin-EDTA treatment.
Dose toxicity studies. Exposure of human
lung epithelial cells to HDI in vitro was per-
formed as described previously (5,6). Brieﬂy,
cells were grown to conﬂuence in 75-cm2 tissue
culture ﬂask, washed three times with PBS, and
exposed to HDI in PBS (containing 1 mM
CaCl2 and 1 mM MgCl2 to prevent detach-
ment). For dose titration, HDI was serially
diluted in acetone before being added to the
cells in a volume of 10 mL PBS, with a ﬁnal
acetone concentration of 0.5% (volume/vol-
ume) and final HDI concentrations ranging
from 300 nM to 30 mM. Samples were shaken
vigorously and rocked for 20 min at room tem-
perature. Control ﬂasks received vehicle alone
in the same volume. For molecular biology
studies, the cells were washed three times with
PBS and immediately lysed in 8 mL of Trizol,
or cultured for additional periods of time in
complete growth media, and then washed again
with PBS and lysed in Trizol. For toxicity stud-
ies, cells were stained with trypan blue, rather
than lysed in Trizol, and counted using a
hemocytometer. Toxicity was based on the per-
centage of dead cells in exposed cultures/per-
centage of dead cells in control cultures. For
immunoﬂuorescence analysis (IFA), cells were
similarly grown on sterilized round glass cover-
slips. Exposure of cells attached to coverslips
was scaled down to adapt to 24-well plates with
identical HDI and vehicle concentrations.
IFA. HDI-exposed airway epithelial cells
on round glass coverslips were ﬁxed for 15 min
with 2% paraformaldehyde in PBS, followed
by permeabilization with 0.1% triton X-100.
Coverslips were washed with PBS and blocked
with 50% goat serum in PBS for 30 min at
room temperature. Preimmune α-ovalbumin
or α-HDI rabbit serum (5,6) was then added
at a 1:200 dilution in 10% goat serum/PBS for
60 min. Coverslips were washed three times in
PBS before secondary antibody (rhodamine-
labeled goat anti-rabbit immunoglobulin γ,
human/mouse absorbed) was added at a 1:400
dilution in 10% goat serum/PBS for 30 min at
room temperature. Coverslips were washed
three times with PBS and mounted on glass
slides with antifade mounting media. Stained
cells were visualized on a Nikon Microphot-
FXA microscope (Melville, NY) at 600 × mag-
niﬁcation under oil.
Microarray. Microarray was performed by
the Yale University School of Medicine
Microarray Center. RNA from exposed cells
was double puriﬁed using Trizol reagent and
RNAeasy columns. RNA (50 µg) obtained
from NCI-H292 cells 2 hr after a 20-min
exposure to HDI or vehicle alone was directly
labeled with cy3 and cy5 and hybridized to the
“in-house” HU-4.6K glass slide, a broad-spec-
trum array. The HU-4.6K array contains the
ﬁrst 4,608 cDNAs (48 × 96-well plates) from
the Research Genetics 40K list (15). The
cDNAs are arrayed in duplicate in a 4 × 4
array with 24 × 24 spots in each of 16 subar-
rays. Fluorescence hybridization data were
acquired on an Axon GenePix 4000A scanner
using GenePix Pro3 software as detailed at the
Yale University School of Medicine
Microarray Center web site (15). Quality con-
trol studies with the HU-4.6K slide and the
image analysis system employed have suggested
that a > 2-fold change in fluorescence ratio
represents a signiﬁcant difference (p < 0.005)
when compared with the appropriate control.
The following IMAGE (Integrated Molecular
Analysis of Genomes and their Expression
consortium) clones from the microarray were
further studied by Northern analysis (Table 1).
Northern blot analyses. To validate
microarray results and to further study the
kinetics of HDI-induced changes in gene
expression patterns, we undertook Northern
blot analyses. RNA was double puriﬁed from
HDI-exposed cells using Trizol followed by
RNAeasy columns. Total RNA (15 µg/lane)
was electrophoresed on a 1.2% agarose gel
using the Northern Max-Gly kit according to
the manufacturer’s instructions. RNA was
transferred to Hybond-N nylon membrane in
20 × saline sodium citrate (SSC) overnight and
immobilized by ultraviolet cross-linking.
Membranes were prehybridized in ULTRAhyb
Buffer at 42°C for 2 hr. Biotin-labeled probes
(see below) were denatured by heating at 90°C
for 10 min, added to the 10 mL of ULTRAhyb
Buffer, and hybridized over night (~16 hr).
After hybridization, the blots were washed
twice in 2 × SSC/0.1% SDS for 10 min at
room temperature and in 0.1 × SSC/0.1%
SDS at 42°C for 15 min. Hybridized probes
were detected with the CDP-Star Brightstar
Biodetect system according to the manufac-
turer’s instructions. Brieﬂy, blots were blocked,
incubated with a 1:1,000 dilution of alkaline
phosphatase-conjugated streptavidin for 30
min, and extensively washed before develop-
ment with chemiluminescence CDP-Star sub-
strate and exposure to X-ray film. The blots
were stripped once in 0.1× SSC/0.1% SDS and
reanalyzed with a β-actin probe. Quantiﬁcation
of RNA signals by densitometry scanning of
the final X-ray film was achieved using the
AlphaImager 2000 documentation and analysis
system by Alpha Innotech Corporation (San
Leandro, CA). The level of each mRNA was
calculated based on the integrated density value
of a constant area and standardized to the
β-actin signal. Three different experiments
were completed with 0, 3, 17, and 30 µM
exposure doses. Student’s t-test was used to
evaluate the statistical signiﬁcance of the change
in mRNA levels of HDI-exposed cells com-
pared with “mock” exposed cells.
Probes. The probes were prepared by biotin
labeling polymerase chain reaction (PCR) prod-
ucts, except for β-actin, which was purchased
from Ambion. For PCR ampliﬁcation of gene
fragments, cDNA was prepared from the airway
epithelial cells using the SuperScript ﬁrst-strand
synthesis system for reverse transcription–PCR
by Gibco BRL Life Technologies, according to
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Table 1. IMAGE clones. 
IMAGE clone no. Gene Bank accession no. Corresponding gene
789376 AA453335 Thioredoxin  reductase
196992  R93124 Dihydrodiol dehydrogenase (AKRC1)
547247 AA085318 Stanniocalcin
194214 R83270 TG-interacting  factor
Table 2. PCR primers for probe generation. 
Gene name Forward (5’ to 3’) Reverse (5’ to 3’) PCR (bp)
Thioredoxin reductase TGAACAACTGTGCCTTGTGG GCCAAATGAGATGAGGAC 380
Dihydrodiol dehydrog. CAGTGTCTGTAAAGCCAG GGTTGAAGTAAGGATGAC 240
TG-interacting factor AGACAGTATGTGGGCATC AAATGTCATGATTGCCCG 360
Stanniocalcin ACATTCTGCAATGGCAGC TCAGCTAACTCTACTGGG 220
Figure 1. Cytotoxicity of HDI to human airway
epithelial cells in vitro. Monolayers of A549 (cir-
cles) and NCI-H292 (squares) cells in tissue culture
flasks were exposed to titrated doses of HDI, and
percentage viability (y-axis) was assessed immedi-
ately or 24 hr after a 20-min exposure. 
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ythe manufacturer’s instructions, using oligo(dT)
primer and 5 µg of RNA/cDNA reaction. Table
2lists the primers used.
For PCR reactions, 2 µL cDNA, 15 pmol
primers, and 45 µL platinum PCR supermix
from Gibco BRL were ampliﬁed for 35 cycles
at 94°C, 58°C, and 72°C. PCR products were
purified from low-melting-point gels and
sequence validated. Next, 100 ng of puriﬁed
PCR products in 10 µL was labeled with the
Brightstar Psoralen-Biotin Nonisotopic
Labeling Kit from Ambion, according to the
manufacturer’s instructions. Labeling and
specificity were verified by dot blot as the
manufacturer suggested and by Southern blot
against different PCR products. For Northern
analysis, probes were used at 0.1–1 ng/mL.
Results
Development of an in vitro HDI exposure sys-
tem. To facilitate investigations on the dose
dependence and kinetics of HDI’s effects on
human airway epithelial cells, we developed
and characterized an in vitro exposure system.
Two different cell lines, A549 and NCI-
H292, were chosen for these studies; both are
hearty immortalized cell types commonly
employed for in vitro studies of human airway
epithelial cell types. A549 cells, a type II-like
alveolar epithelial cell, are one of the most
widely used cell lines for studying human air-
way epithelial cell biology. NCI-H292 cells
are mucoepidermoid type I-like alveolar
epithelial cells. Analysis of the effects of HDI
encompassed toxicity studies, IFA, microarray,
and Northern blot analyses. Toxicity was
based on trypan blue dye exclusion as evi-
dence of cell viability after exposure. IFA stud-
ies were analyzed microscopically for evidence
of HDI binding and uptake, which was
detected with an HDI-specific antiserum.
Expression proﬁling was accomplished based
on cDNA hybridization to a broad-spectrum
4.6K human gene chip and further defined
based on quantitative measurements of
mRNA levels by Northern blot analysis.
In vitro toxicity studies. Initially we deter-
mined the in vitro toxicity of HDI to A549
and NCI-H292 cells grown as monolayers in
flasks, through dose titration studies. Cells
were exposed to HDI concentrations ranging
from 300 nM to 30 mM and viability was
assessed. A 20-min exposure to doses > 3 mM
was cytotoxic, whereas cells exposed to doses
< 300 µM remained viable when analyzed
immediately after exposure (Figure 1).
However, when cells were analyzed 24 hr
after HDI exposure, substantial cell death
(< 10% viability) was noted in cultures
exposed to concentrations > 300 µM, whereas
cultures exposed to doses < 30 µM remained
> 90% viable. The toxicity of HDI to A549
and NCI-H292 cells was comparable over
this broad exposure dose range.
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Figure 2. Binding of HDI to human airway epithelial cells: IFA of A549 cells immediately after a 20-min exposure
to a subcytotoxic dose (30 µM) of HDI. Phase contrast (A,C) and immunoﬂuorescent (B,D) micrographs were
probed with α-HDI rabbit serum (A,B) or α-ovalbumin rabbit serum (C,D). Arrows point to foci of HDI staining.
Figure 3. Time course of binding and uptake of HDI by human airway epithelial cells: IFA (using α-HDI rab-
bit serum) of A549 cells at different times after a 20-min exposure to a subcytotoxic dose (30 µM) of HDI.
The four horizontal rows (A–D) show different microscopic ﬁelds from one experiment to provide a sense
of the range of staining patterns observed at different time points and the unique morphology and subcel-
lular localization of HDI in individual cells. 
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DBinding of HDI to human airway epithe-
lial cells. To visualize the binding of HDI to
human airway epithelial cells in vitro, we per-
formed IFA using an HDI-speciﬁc antiserum
developed by our laboratory (5,6). Immediately
after a 20-min exposure to 30 µM HDI, airway
epithelial cells exhibited foci of HDI-speciﬁc
staining along the cell surface. Microscopic
comparison of ﬂuorescence and phase-contrast
images revealed that these concentrated areas 
of cell-associated HDI corresponded to
“droplets,” structurally consistent with micelles
of HDI (Figure 2). The observed foci of cell-
associated HDI appeared to be taken up and
distributed within the cell during a 3-hr period
after exposure (Figure 3).
Molecular changes induced by HDI expo-
sure. We screened for genes that may be selec-
tively induced by HDI exposure using
microarray analysis and assumed a priori that
any potential effects of HDI would be time and
dose dependent. As a starting point for these
studies, we analyzed cells that were exposed to
the highest nontoxic dose of HDI and then
cultured them for additional periods of time to
permit changes in cellular mRNA levels to
occur. When this approach was used to com-
pare mRNA proﬁles from NCI-H292 cells 2 hr
after a 20-min exposure to 30 µM HDI (rela-
tive to control cultures identically exposed to
vehicle), increases (> 2.0-fold) were noted in
just 4 of 4,608 transcripts analyzed. Figure 4
shows fluorescent images and corresponding
false color overlay for 4 of 16 quadrants of a
representative 4.6K gene microarray. The read-
ily apparent differentially expressed cDNA
hybridization signals are circled and correspond
to thioredoxin reductase, a dihydrodiol dehy-
drogenase, aldo-keto reductase C1 (AKRC1),
stanniocalcin, and TG-interacting factor
(Figure 4A–D, respectively). Similar results
were obtained with A549 cells, although the
relative changes in gene expression were not as
great as those observed with NCI-H292 cells
because baseline levels of each of these mRNA
were higher in A549 cells (data not shown).
To validate the results of our microarray
studies and further analyze the kinetics
and dose dependence of HDI-induced gene
expression, we performed Northern blot analy-
sis with NCI-H292 cells exposed to titrated
doses of HDI and cultured for varying
amounts of time after exposure. For the
selected genes, mRNA levels were quantitated
as described, and changes induced by different
doses were compared with “mock exposed”
cultures. As shown in Figures 5 and 6, thiore-
doxin reductase, dihydrodiol dehydrogenase,
stanniocalcin, and TG-interacting factor
mRNA levels were increased in a dose-depen-
dent manner. A statistically signiﬁcant increase
in mRNA levels for all four of these proteins
was observed as early as 2 hr after exposure to
doses ≤ 30 µM (Figure 6). The mRNA levels
for these different genes remained increased for
up to 4 hr after exposure and returned to base-
line by 24 hr (data not shown).
Discussion
This report characterizes previously unde-
scribed effects of HDI exposure on human air-
way epithelial cells. The study also
demonstrates the potential advantages of
microarray technology as an aid to understand-
ing the effects of chemical exposures on bio-
logic systems. The experiments were based on
previous investigations that have demonstrated
that speciﬁc human airway epithelial cell pro-
teins become conjugated with HDI after expo-
sure (5–7), and the hypothesis that
HDI–epithelial cell protein conjugation may
induce pathogenic functional changes. In the
present studies, we coupled microarray (> 4K
genes) technology with an in vitro HDI expo-
sure system using airway epithelial cell lines to
screen for genes whose message levels are signif-
icantly increased by HDI. The kinetics and
HDI dose dependence of increases in mRNA
Figure 4. Expression proﬁling of HDI-exposed human airway epithelial cells: representative data of a cDNA
microarray comparing NCI-H292 cells 2 hr after a 20-min exposure to 30 µM HDI or vehicle control. Raw ﬂuo-
rescence image of unexposed (cy5 labeled) and exposed cells (cy3 labeled) and corresponding false-color
overlays of 4 of 16 subquadrants are shown. Circled are the duplicate cDNA loci corresponding to thioredoxin
reductase (A); a dihydrodiol dehydrogenase, AKRC1 (B); stanniocalcin (C); and TG-interacting factor (D).
Cy5-label
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D
Cy3-label False color
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(AKRC1) encodes a protein previously shown
to be speciﬁcally susceptible to HDI conjuga-
tion (6), were veriﬁed by Northern blot studies.
The in vitro exposure model was also used to
visualize the interaction of HDI with living air-
way epithelial cells by IFA and provides new
evidence for the rapid binding and uptake of
HDI by exposed cells. Together with previ-
ously published reports, the data yield insights
into pathways through which HDI may exert
its toxic effects on airway epithelial cells.
The initial studies of this report established
an in vitro system to permit titrated HDI
exposure of human airway epithelial cell lines.
First, we determined the toxicity of HDI to
two different types of human airway epithelial
cells, A549 and NCI-H292, which had not
been previously established. We demonstrated
that a 20-min exposure to doses < 30 µM HDI
did not cause measurable cytotoxicity over a
24-hr period. These concentrations are at least
2,000-fold less than the concentration of HDI
present in aerosol droplets of autobody shop
paints, which typically contain 1% HDI (~ 60
mM). Given that HDI aerosols have been
shown to deposit in the airways of exposed
workers, the concentrations of HDI used in
the present studies are relevant to current com-
mon occupational exposures and possibly also
to environmental exposures (16,17).
The ability of HDI to bind and be taken
up by airway epithelial cells over time was fur-
ther tested by IFA using an HDI-speciﬁc poly-
clonal antiserum generated in our laboratory
(5,6). These IFA studies provide, for the ﬁrst
time, visual evidence of the afﬁnity of HDI for
live cells. The fluorescence staining pattern
observed suggests that HDI initially interacts
with the cell membrane and is taken up within
3 hr after exposure. The cell-associated HDI
foci observed in these studies resemble droplet-
like structures that are consistent with HDI
micelles and the tendency for HDI to form
emulsions in aqueous solutions (4), but might
also reﬂect localized HDI–protein aggregates.
On the basis of current IFA studies and
previous reports suggesting that diisocyanates
can bind and be taken up by airway epithelial
cells (5,6,11), we investigated the possibility
that HDI exposure may also result in speciﬁc
changes in gene expression. To screen for
HDI-sensitive airway epithelial cell genes, we
used microarrays to expression proﬁle in vitro
exposed cells. HDI induced differential expres-
sion in only a limited number of 4,608 genes
tested. We subsequently used Northern blot
analyses to conﬁrm the microarray results for
the four genes whose message levels were up-
regulated > 2-fold by microarray analysis. The
limited number of genes (≤ 8) whose message
levels were decreased or less strongly increased
represent other potentially HDI-sensitive genes
that may be investigated in future studies.
Two of the up-regulated genes AKRC1
and thioredoxin reductase are relevant to cel-
lular thiol-redox homeostasis. One of these,
AKRC1, encodes the same dihydrodiol dehy-
drogenase protein previously shown to be sus-
ceptible to HDI conjugation (6) and belongs
to a family of oxidant stress-induced enzymes
that detoxify hydrocarbons (18–20). AKRC1
is one of just four HDI-conjugated proteins
previously identified in exposed human air-
way epithelial cells and appears to be espe-
cially sensitive to low exposure concentrations
(6). The conjugation of AKRC1 protein with
HDI and the up-regulation of its mRNA
after exposure suggest that this protein may be
important in the metabolism of HDI and/or
the repair of oxidants resulting from exposure.
Thioredoxin reductase is an essential
enzyme important in maintaining cellular
thiol-redox homeostasis and defense against
oxidant stress and also mediates important co-
cytokine activities via its substrate thioredoxin,
which can act as a potent T-cell growth factor
(21–30). Increases in thioredoxin reductase
may thus not only signal HDI-induced thiol-
redox imbalance but also provide an “antigen-
receptor–independent” mechanism by which
epithelial cell responses to exposure may pro-
mote immunologic sensitization to HDI via
either a) epithelial cell–derived cytokines/
chemokines under redox-dependent transcrip-
tional regulation (13,14) or b) immunologically
active thioredoxin (21–25). Interestingly,
thioredoxin reductase contains selenium, which
is thought to be crucial to its role as a cellular
sensor of redox potential and which, based on
its biochemical properties, should be highly
susceptible to nucleophilic addition reactions
with diisocyanates (10,28,31).
Of the other two genes we have docu-
mented to be up-regulated by HDI exposure,
one, TG-interacting factor, possesses impor-
tant regulatory capacity, through its ability to
block retinoic acid signaling (32,33). The
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Figure 5. Northern blot analysis of HDI-induced changes in gene expression. Total RNA from NCI-H292 cells
exposed to titrated, subcytotoxic doses of HDI was obtained at varying times after a 20-min exposure and
hybridized with probes for the genes shown. Lane 1, vehicle control; lane 2, 3 µM; lane 3, 17 µM; lane 4, 30 µM.
Thioredoxin reductase Stanniocalcin
Dihyrodiol dehydrogenase TG-Interacting factor
3.8 kb
β-actin
1 hr 2 hr 3 hr 4 hr
1234 1234 12341234
1 hr 2 hr 3 hr 4 hr
1234 1234 12341234
4 kb
β-actin
1.4 kb
β-actin
1 hr 2 hr 3 hr 4 hr
1234123412341234
2 kb
β-actin
1 hr 2 hr 3 hr 4 hr
1234123412341234
Figure 6. Quantitation of HDI-induced changes in gene expression. Relative mRNA levels for the genes
shown were quantitated relative to β-actin. The average ± SE of three experiments are depicted. 
*Statistically signiﬁcant (p < 0.005) compared with vehicle control.
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30 µMother, stanniocalcin, encodes a protein whose
function in humans remains uncertain but is
highly homologous to a ﬁsh hormone highly
expressed in the gills (the fish equivalent of
lungs), where it plays an important role in
Ca2+ homeostasis (34). The relevance of these
two genes to diisocyanates has not previously
been considered and may identify signaling
pathways that human airway epithelial cells
utilize in their response to exposure.
One limitation of the present studies is
that, to permit consistent, well-controlled expo-
sures, we employed in vitro exposure of immor-
talized human airway epithelial cell lines. Thus,
the in vivo relevance of the observed responses
in normal cells in situ remains to be tested.
Such in vivo studies in humans are extremely
challenging because of practical and ethical
considerations, and animal models are limited
by anatomic and metabolic differences with
humans. However, several ﬁndings support the
relevance of the present studies—speciﬁcally,
the capacity of diisocyanates to alter airway
epithelial cell thiol-redox homeostasis
(9–11,35). Previously reported in vitro and in
vivo studies have suggested that HDI and TDI
can enter bronchial epithelial cells, conjugate
with and result in a rapid reversible drop in lev-
els of intracellular glutathione (9–11,35). The
present data, especially the ﬁnding that HDI
exposure increases thioredoxin reductase
expression, are consistent with these studies and
suggest a mechanism, via thioredoxin, that cells
may use to counteract the thiol-depleting
effects of exposure. Further studies will be nec-
essary to determine the mechanisms that con-
trol gene transcription of the identified
HDI-responsive genes, whether these changes
result in increased protein levels, and whether
the findings extend to other diisocyanates.
Additionally, the potential protective effects of
naturally occurring compounds in the lung
(i.e., surfactants, proteins, and antioxidants)
may be investigated using the in vitro exposure
system we have deﬁned.
This study also demonstrates the poten-
tial utility and feasibility of microarray tech-
nology in beginning to understand the
complex biologic effects of human exposure
to chemicals such as HDI. The results
demonstrate the selectivity and validity of
microarray analysis under well-controlled
experimental conditions. Only a select num-
ber of genes were found to be up-regulated by
HDI using microarray analysis, and these
effects were confirmed using Northern blot
analysis. Although there has been rapidly
growing interest in microarray technology,
this is one of the ﬁrst reports demonstrating
its utility in studying the effects of exposure
to occupationally relevant chemicals.
In summary, the present study develops an
in vitro exposure model to characterize the
effects of HDI on human airway epithelial cell
lines and defines specific molecular changes
that result from exposure. Importantly, the data
support previous studies suggesting that diiso-
cyanates can enter airway epithelial cells and
upset cellular thiol-redox homeostasis. Given
that many pro-inflammatory cytokines/
chemokines are under the control of redox-sen-
sitive transcription factors, the present results
suggest an “antigen-receptor-independent”
mechanism through which HDI may promote
airway inﬂammation and asthma. Future stud-
ies should determine whether individual differ-
ences exist in airway epithelial cell sensitivity to
HDI and whether these potential differences
help explain the widely disparate responses of
exposed workers.
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